Tomorrow, March 17, 2022 Tune in via livestream as Greg Piefer joins other industry experts to help shape vision for commercial fusion energy Today, the Biden-Harris Administration released additional information [...]
SHINE Medical Technologies LLC today announced it has received a $15-million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA). The award was made by the agency as part of its effort to establish a reliable, U.S.-produced supply of molybdenum-99 (Mo-99), the most commonly used medical isotope.
SHINE Breaks Ground on Medical Isotope Production Facility - First Commercial Sales of Life-Saving Medical Isotopes Expected in 2022. SHINE held a groundbreaking ceremony today to celebrate the start of construction of its US medical isotope production facility in Janesville, Wisconsin. The groundbreaking comes just one month after SHINE was transferred 91 acres of land across from the Southern Wisconsin Airport. Once complete, the facility will be home to eight of SHINE’s accelerator-based medical isotope production systems, capable of producing over one-third of global demand for the most widely-used medical isotope, molybdenum-99.
SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it will host a key opinion leader (KOL) meeting on the topic of Nuclear Medicine and Diagnostics on June 15th in New York City.
January 11, 2016 - The University of Wisconsin-Madison College of Engineering has awarded Dr. Greg Piefer, founder and CEO of SHINE Medical Technologies, Inc. (SHINE) the Early-Career Achievement Award.